Detection of clinically relevant antibodies pretransplant and posttransplant with PRA-STAT

Neylan, John F.; Smet, W. De; Stijlemans, Benoı̂t; Brinker, Karl R.; Gonwa, Thomas A.; Moran, John; Segers, Annelise

doi:10.1016/s0041-1345(96)00289-8

Cited by 5 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This may be the reason why all anti-HLA antibodies might not be detected in this study (20). In PRA studies which CDC method was used for detection of anti-HLA antibodies, it is known that some anti-HLA antibodies could not be detected (21). In the study by Mihaylova et al…”

Section: Discussionmentioning

confidence: 71%

Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation

Ayna¹,

Çalışkan²,

Çiftçi³

et al. 2013

Balkan Med J

View full text Add to dashboard Cite

Objective: In this study, we aimed to investigate the incidence, dynamics and profiles of human leukocyte antigen (HLA)-directed antibodies developed after transplantation and their impact on graft rejection and outcome in kidney recipients.Study Design: Prospective follow-up study.Material and Methods: A total of 56 kidney recipients were monitored at 1 st , 6 th and 12 th months for the development of anti-HLA antibodies using bead based flow-cytometry assays (Flow PRA tests).Results: In 21 (37.5%) patients, panel reactive antibodies (PRA) was positive after transplantation, however, in 35 (62.5%) patients PRA was found negative. Twelve (57.1%) patients with post-transplantation HLA-reactive antibodies [PRA (+)] and 8 (22.9%) patients with no detectable alloantibodies [PRA (-)] were developed allograft rejection (p=0.010). In the PRA positive patient group the rates of early period infection and delayed graft function (DGF) were higher than the PRA negative patient group. Serum creatinine levels of PRA positive group at 6. and 12. months after transplantation were significantly higher than the PRA negative group (p=0.015 and p=0.048, respectively). The rejection rates of patients who had class I and II HLA antibodies were significantly higher than the patients who had either class I or II HLA antibodies (p=0.011). Acute rejection rates were significantly higher in patients who had class I and II HLA antibodies at the first month (p=0.007). Conclusion:Higher occurrence of rejection episodes in PRA positive group may show the importance of anti-HLA antibody monitoring using Flow-PRA after renal transplantation as a prognostic marker in terms of graft survival.

show abstract

Section: Discussionmentioning

confidence: 71%